XLumena Lands $25,000,000 Series C Funding

  • Feed Type
  • Date
    12/3/2013
  • Company Name
    XLumena
  • Mailing Address
    453 Ravendale Drive Mountain View, CA 94043
  • Company Description
    Xlumena is the leader in the developments of image-guided therapeutic endoscopy products specializing in advanced implants and devices that address multiple markets. Collaborating with top physicians in the field, Xlumena focuses on technology that advances therapy to the next level.
  • Website
    http://www.xlumena.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Xlumena will use the Series C proceeds to expand global commercialization efforts for its AXIOS family of devices and continue the process of bringing this innovative platform to the US interventional endoscopy community.
  • M&A Terms
  • Venture Investor
    Third Point
  • Venture Investor
    Prism VentureWorks
  • Venture Investor
    Charter Life Sciences Fund
  • Venture Investor
    Ascent Biomedical Ventures
  • Venture Investor
    Aperture Venture Partners

By posting a comment, you agree to our terms and conditions.